Literature DB >> 8738940

Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study.

G Villa1, A Solida, E Moro, M Tavolozza, A Antinori, A De Luca, R Murri, E Tamburrini.   

Abstract

Seventy-eight asymptomatic HIV-seropositive (aHIV) subjects were examined by means of an extensive neuropsychological test battery in comparison with 32 HIV-seronegative controls. They were also tested with regard to CD4+ and serum p24 antigen. Fifty-six of them completed a clinical follow-up of 12 up to 36 months and 35 also underwent a second session of neuropsychological, CD4+ and p24 antigen assessments at a 12- to 18-month interval from the first session. Results obtained lead to the following conclusions: (a) even among aHIV subjects there is a significant prevalence (28.2%) of cognitive abnormalities for which no cause other than HIV can be found, and therefore this suggests the possible development of HIV-related brain damage since the earliest stages of infection; (b) most sensitive to early HIV-related cognitive impairment are timed psychomotor tasks and memory tasks which require attention, learning and 'active' monitoring or retrieval of information; (c) during the early asymptomatic stages of HIV infection, there is no clear-cut evidence of a cross-sectional relationship between cognition and immunological/ virological markers (at least in the high ranges of CD4+ cell counts considered here); only in relatively more advanced stages does this relationship become evident in the subgroup of aHIV subjects with cognitive abnormalities; (d) the presence of cognitive abnormalities in early HIV infection is predictive of a further decrease in cognitive functioning and faster progression to AIDS-this latter reflected by a faster rate of decline in the number of CD4+ cells and by an increase in positivity of serum p24 antigen.

Entities:  

Mesh:

Year:  1996        PMID: 8738940     DOI: 10.1159/000117228

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  13 in total

1.  Relationship of ethnicity, age, education, and reading level to speed and executive function among HIV+ and HIV- women: the Women's Interagency HIV Study (WIHS) Neurocognitive Substudy.

Authors:  Jennifer J Manly; Clifford Smith; Howard A Crystal; Jean Richardson; Elizabeth T Golub; Ruth Greenblatt; Esther Robison; Eileen M Martin; Mary Young
Journal:  J Clin Exp Neuropsychol       Date:  2011-08-23       Impact factor: 2.475

Review 2.  Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research.

Authors:  Lisa R Norman; Michael Basso; Anil Kumar; Robert Malow
Journal:  Curr Drug Abuse Rev       Date:  2009-05

3.  Antiretroviral neurotoxicity.

Authors:  Kevin Robertson; Jeff Liner; Rick B Meeker
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

4.  A Self-Report Measure to Detect Neurocognitive Impairment among Incarcerated People Living with HIV in Malaysian Context: An Exploratory Factor Analysis.

Authors:  Roman Shrestha; Damian Weikum; Michael Copenhaver; Frederick L Altice
Journal:  Int J Ment Health Addict       Date:  2017-04-03       Impact factor: 3.836

5.  Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients.

Authors:  David F Tate; Allison Delong; Daniel E McCaffrey; Kinga Kertesz; Robert H Paul; Jared Conley; Troy Russell; Kathleen Coop; Fizza Gillani; Timothy Flanigan; Karen Tashima; Joseph W Hogan
Journal:  Arch Clin Neuropsychol       Date:  2011-08-25       Impact factor: 2.813

6.  Neuroprotective activities of CEP-1347 in models of neuroAIDS.

Authors:  Dawn Eggert; Prasanta K Dash; Santhi Gorantla; Huanyu Dou; Giovanni Schifitto; Sanjay B Maggirwar; Stephen Dewhurst; Larisa Poluektova; Harris A Gelbard; Howard E Gendelman
Journal:  J Immunol       Date:  2009-12-04       Impact factor: 5.422

Review 7.  Neurotoxicity in the Post-HAART Era: Caution for the Antiretroviral Therapeutics.

Authors:  Ankit Shah; Mohitkumar R Gangwani; Nitish S Chaudhari; Alexy Glazyrin; Hari K Bhat; Anil Kumar
Journal:  Neurotox Res       Date:  2016-06-30       Impact factor: 3.911

8.  The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis.

Authors:  Roman Shrestha; Damian Weikum; Michael Copenhaver; Frederick L Altice
Journal:  AIDS Behav       Date:  2017-04

Review 9.  Effects of antiretroviral therapy on cognitive impairment.

Authors:  Kevin J Liner; Colin D Hall; Kevin R Robertson
Journal:  Curr HIV/AIDS Rep       Date:  2008-05       Impact factor: 5.071

10.  Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders.

Authors:  Dawn Eggert; Prasanta K Dash; Nawal Serradji; Chang-Zhi Dong; Pascal Clayette; Francoise Heymans; Huanyu Dou; Santhi Gorantla; Harris A Gelbard; Larisa Poluektova; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2009-06-21       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.